An Atypical Cutaneous Reaction to Rivastigmine Transdermal Patch | Zendy

Teresa Grieco | Zendy; María Pía Rossi | Zendy; Valentina Faina | Zendy; Iolanda De Marco | Zendy; P. D. Pigatto | Zendy; Stefano Calvieri | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

An Atypical Cutaneous Reaction to Rivastigmine Transdermal Patch

Author(s) -

Teresa Grieco,

María Pía Rossi,

Valentina Faina,

Iolanda De Marco,

P. D. Pigatto,

Stefano Calvieri

Publication year - 2011

Publication title -

journal of allergy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.39

H-Index - 3

eISSN - 1687-9791

pISSN - 1687-9783

DOI - 10.1155/2011/752098

Subject(s) - rivastigmine , transdermal patch , transdermal , medicine , dermatology , cholinesterase , dementia , anesthesia , drug , pharmacology , donepezil , disease

Rivastigmine is a cholinesterase inhibitor which improves cognitive function and is currently being used in patients with mild to moderate Parkinson's and Alzheimer's dementia. This drug can be given orally or topically, as transdermal patch. The latter form is currently used for most excellent compliance and few side effects. The most common cutaneous side effects are irritative dermatitis. We report the second case of active sensitization by the rivastigmine-patch in a patient suffering from Alzheimer's dementia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research